Steve Pakola

Steve Pakola

Company: REGENXBIO

Job title: Chief Medical Officer

Seminars:

Chair Led Q&A: Making Strides Forward in Drug Delivery & Dosing 2:55 pm

Read more

day: Day One

Utilizing Gene Therapy to Induce Long Term Treatment of Wet AMD & DME 2:30 pm

Exploring the durability of gene therapy in providing long term treatment for Wet AMD & DME Understanding the safety issues surrounding the constant and permanent production of anti-VEGF into the back of the eye Potential treatment limitations for clinicians administering a gene therapy solution to patientsRead more

day: Day One

Panel Discussion: Ending the Burden of Monthly Treatments – Mechanisms to Increasing the Durability & Accessibility of Wet AMD & DME Therapeutics 10:45 am

Exploring extended-duration therapeutic possibilities with a focus on the anti-VEGF pathway Understanding how to increase drug durability and bring more convenient, safe drug delivery options to patients Achieving longer-term VEGF suppression through gene therapy, oral therapeutics or combination approaches with other drug modalitiesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.